Tuesday, August 7, 2012

Orphan Grant program

1. Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant

FDA is announcing the availability of grant funds for the support of FDA's Office of Orphan Products Development (OPD) grant program. The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products.

For more information, including deadlines, please visit: OPD Grant Program


Post a Comment

Subscribe to Post Comments [Atom]

Links to this post:

Create a Link

<< Home